Therapeutic immunization strategies for the control of HIV-1. by Dorrell, L

Therapeutic immunization for the control of HIV-1: where are we now? by Dorrell, L

Therapeutic immunization for the control of HIV-1: where are we now? by Dorrell, L

Twenty-five years of HIV research: what we have learned and what we still need to know by Dorrell, L

Recent advances in understanding and preventing human papillomavirus-related disease by Hellner, K, Dorrell, L

Vulvovaginitis due to fluconazole resistant Candida albicans following self treatment with non-prescribed triazoles. by Dorrell, L, Edwards, A

Comment on clinical development of candidate HIV vaccines: different problems for different vaccines. by McMichael, A, Dorrell, L

The immune response to HIV by McMichael, A, Dorrell, L

Development of prophylactic vaccines against HIV-1. by Schiffner, T, Sattentau, Q, Dorrell, L

Therapeutic HPV vaccines by Hancock, G, Hellner, K, Dorrell, L

Therapeutic targeting of HIV reservoirs: how to give T cells a new direction by Yang, H, Wallace, Z, Dorrell, L

Pathophysiology of ischaemic heart disease by Pocock, MO, Dorrell, L, Cicconi, P

Exposure to zidovudine adversely affects mitochondrial turnover in primary T cells. by Wallace, Z, Sanderson, S, Simon, A, Dorrell, L

Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction. by Hanke, T, Goonetilleke, N, Mcmichael, A, Dorrell, L

Hypophosphataemia in HIV-positive patients taking non-tenofovir-containing antiretrovirals by Wainwright, E, Dorrell, L, Sherrard, J, Shine, B

Erratum: Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction (Journal... by Hanke, T, Goonetilleke, N, McMichael, A, Dorrell, L

Hypophosphataemia with non-tenofovir-containing antiretroviral therapy. by Wainwright, E, Sherrard, J, Duncan, S, Shine, B, Dorrell, L

Evaluation of circulating gut-homing T cells as a marker of HIV-1 progression and immune reconstitution by Dorrell, L, Clutton, G, Hancock, G, Corrah, T, Fox, J

Phase I Clinical Trial HIV-CORE002 of a Universal T-cell Vaccine: Mapping of CD8+ T Cell Epitopes. by Borthwick, N, Ahmed, T, Dorrell, L, Van Hateren, A, Elliot, T, Hanke, T

pTHr.HIVA and MVA.HIVA vaccines (gag p24/p17) augment CD4+T cell responses in chronically infected HIV-1 patients on HAART by Ondondo, B, Yang, H, Rowland-Jones, S, Hanke, T, McMichael, A, Dorrell, L